Chief Executive Officer and Director
Mr. Durbin joined Viveve in early 2013 and became Chief Executive Officer and Director in May 2018. He previously served as the Company’s Chief Financial Officer and has been instrumental in the Company’s growth. He is committed to leading the Company and the clinical and commercial development of its innovative CMRF technology to solidify its position as a global leader in women’s intimate health. Mr. Durbin’s 25-year career in the life sciences industry covers corporate finance, strategy, clinical, and operational experience. Prior to joining Viveve, he was chief financial officer of Aastrom Biosciences, Inc., a publicly traded, cardiovascular cell therapy company. In 2004, Mr. Durbin began his six years as chief operating and financial officer for Prescient Medical, Inc. ("PMI"), a privately held company that developed diagnostic imaging catheters and coronary stents designed to reduce deaths from heart attacks. Prior to PMI, he spent several years as a financial consultant for two publicly traded biotech companies, Scios, Inc. – a Johnson & Johnson company, and Alteon, Inc. Mr. Durbin began his corporate finance career as an investment banker in the healthcare and M&A groups at Lehman Brothers Inc., where he focused on mergers and acquisitions and financings for the life science industry. At Lehman, he successfully executed over $5 billion in transactions for medical device and biotech companies. Preceding his advance into corporate finance, he served as a Director of Neurophysiology for Biotronic, Inc.
Mr. Durbin received a B.S. from the University of Michigan and an M.P.H. in Health Management with Honors from the Yale University School of Medicine and School of Management.
Senior Vice President of Regulatory and Quality Affairs
Suzon Lommel, Viveve’s Senior Vice President of Regulatory and Quality Affairs, joined the Company in 2016 with more than 30 years of experience in the medical device industry developing regulatory and quality systems. Prior to joining Viveve, she was Global Vice President of Regulatory and Quality Affairs at Ulthera, Inc. which was acquired by Merz Aesthetics in July 2014. Her prior experience includes executive and senior management roles at Breathe Technologies, Inc., FoxHollow Technologies, Inc., Advanced Stent Technology, and Boston Scientific. Ms. Lommel has extensive experience with the U.S. Food and Drug Administration and international regulatory agencies. She has authored numerous 510k, IDE, PMA, and international submissions.
Ms. Lommel holds a degree in Physics from Moorpark College.
Senior Vice President of Finance and Administration, Principal Accounting and Financial Officer
Mr. Robbins joined Viveve as Vice President of Finance in July 2014 and was promoted to Senior Vice President of Finance and Administration in January 2021 having served as Vice President of Finance and Administration since May 2017. In May 2018, he assumed expanded responsibilities and was appointed as the Company’s Principal Accounting Officer, and in November 2018, he became the Principal Accounting and Financial Officer. Mr. Robbins has over thirty years of accounting and finance experience in both industry and public accounting. Prior to joining Viveve, he provided accounting, finance, and business consulting services for various biotech companies. From 2010 to 2012 he served as vice president of finance and administration for Auxogyn, Inc., a privately held medical technology company focused on advancing women’s reproductive health by translating scientific discoveries in early embryo development into clinical solutions that improve patient outcomes invitro fertilization (IVF) procedures. Mr. Robbins served as director of finance and vice president of finance from 2004 to 2010 for Micrus Endovascular, Inc., a company which develops, manufactures, and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Prior to Micrus Endovascular, he served at Genitope Corporation as corporate controller, a biotechnology company focused on the research and development of novel immunotherapies for the treatment of cancer. From 1995 to 2001, he served in management positions for high technology companies including Extricity, Inc., InVision Technologies, Inc., and Truevision, Inc. and was in the audit practice of Price Waterhouse, LLP from 1987 to 1995.
Mr. Robbins received his Bachelor of Business Administration with a concentration in accounting from the University of Texas at Austin and is a Certified Public Accountant.
Doug Massey, Ph.D.
Vice President of Clinical and Medical Affairs
Dr. Massey, Vice President of Clinical and Medical Affairs, joined Viveve with 30 years of experience working in the Pharmaceutical and Medical Device industries. He began working in Urology by leading the pivotal clinical studies of tolterodine for overactive bladder syndrome in the United States and Canada. Since that time, Dr. Massey has held various leadership positions in both Clinical and Medical Affairs at companies including Pharmacia/Pfizer, Roche, and Genentech. In 2018, he started working for Viveve as a consultant leading the Clinical and Medical Affairs departments. He successfully completed multiple preclinical and clinical studies in his consultancy role at the Company and accepted the position of Vice President, Clinical and Medical Affairs in November 2020.
Dr. Massey received a B.S. in Microbiology from Colorado State University and a Ph.D. in Biochemistry from Rutgers University.
Marty Kerber, P.E.
Vice President of Research, Development, and Operations
Marty joined Viveve, Inc. in January of 2018 as Vice President of Operations and assumed leadership of the company's research and development activities the following year. He has 30 years of extensive experience in the medical device field. Serving in senior leadership roles at multiple device companies, Marty's expertise spans engineering, manufacturing operations, contract manufacturer and supply chain management, Lean/Six Sigma processes, product development and launches, and program management. Additionally, he has held customer service, information technology, and intellectual property portfolio management responsibilities.
Previously, as Chief Operating Officer and Engineer at inSleep Health, Marty established the manufacturing organization and drove commercialization of its innovative sleep disorder breathing product. In his capacity as General Manager of MME Group, Inc., he took the organization from tool-making to a contract manufacturing company that created highly regulated products for Fortune 500 medical companies. As Vice President of Engineering at Covidien, Ltd., Marty realigned the organization in preparation for separation from Tyco (TYC) and created the Advanced Manufacturing Engineering function to support a $50 million New Product Introduction spend. He holds seven patents and numerous professional certifications and licenses.
Marty received his B.S. degree in Engineering Mechanics from the U.S. Air Force Academy, an M.S. degree in Materials Engineering from the University of Alabama, and an M.B.A. in Production and Operations Management from the University of Colorado.
Vice President of U.S. Sales
Mr. Lewis, Vice President of U.S. Sales, joined Viveve in December 2016 as the Western U.S. and Canadian Director of Sales. In this position, Mr. Lewis and his team led the U.S. in new Viveve System placements and revenue in 2017 and 2018. In August 2019, he was promoted to Senior Director of Customer Care. He directed Viveve’s Customer Service department and the newly formed team of Marketing Support Specialists to support customers’ marketing efforts and drive consumable sales and utilization. Mr. Lewis accepted the promotion to Vice President of U.S. Sales in December of 2020.
Before joining Viveve, Mr. Lewis served four years as Regional Director, Merz North America, Aesthetic Device Division. He was responsible for capital and consumable sales of $50M annually and directed a team of 12 capital and consumable sales professionals. In April 2016, he was part of the commercial launch of the Cellfina™ System that in 12 months became the market leader generating over $15M in sales. Before Merz, he served as a Clinical Sales Representative at Intuitive Surgical and was responsible for launching and growing robotic surgery programs focused on Urology and Gynecology specialties. As part of his role at Intuitive, Mr. Lewis managed one of only 12 Gynecology Epicenter sites in the U.S., which supported the training of new surgeons. Preceding Intuitive Surgical, he worked four years as a successful Area Sales Manager at Lumenis, Inc., earning multiple sales and performance awards.
Mr. Lewis received his B.S. in Occupational Health from Indiana State University.
Vice President of International Sales
Mr. Sinclair, Vice President of International Sales, joined Viveve in April 2015 with over 20 years of international distributor management and direct operational experience for medical device and aesthetic companies, with a focus in Asia. His success in building and managing diverse international teams in sales, business development, marketing, and training earned him promotions from Managing Director of Asia in 2015 to Vice President of Asia Pacific in 2017. Jeff’s skill in establishing Viveve’s innovative dual-energy technology platform in the women’s intimate health industry and increasing practitioner device utilization in significant regional and global markets advanced him to his current leadership position with responsibility for all Viveve global markets and sales outside of the United States. Before joining Viveve, Mr. Sinclair built successful business platforms holding management positions with device companies including Lumenis, Laserscope, Obagi, and Restoration Robotics.
A native Bay Area Californian, he has primarily resided in Seoul, Korea over the last 25 years. Mr. Sinclair served in the United States Marine Corps infantry for eight years and earned a Bachelor of Arts degree from the University of California at Davis. In addition to English, his languages include Korean, Japanese, conversational Chinese, and Spanish.
Vice President of Global Marketing
Mr. Kaiser joined Viveve in 2019 and assumed the leadership role as Vice President of Global Marketing in January 2021. He has more than 25 years of senior management experience in the health care, pharmaceutical, and medical device industries. Prior to joining Viveve, Mr. Kaiser worked at Aytu BioScience from July 2016 to January 2019, where he was instrumental in the organization’s entrance into the urology market. Preceding Aytu BioScience, he served as Director of Marketing at Astellas Pharmaceuticals, Inc. where he led the professional marketing launch in 2012 of Myrbetriq®, the first beta-3 agonist drug for overactive bladder. Additional professional experience includes marketing roles at Amgen, TAP Pharmaceuticals, Pharmacia, Knoll Pharmaceutical Company, and a family-owned home health care company. During this tenure, Gary gained extensive management experience launching numerous biotech and consumer products, building brands, and developing organizations for commercial success in various therapeutic areas.
Mr. Kaiser received a B.S. in Marketing and an M.B.A. in Marketing from the University of Montana.
Vice President of Human Resources
Ms. McMillan joined Viveve in 2017 as Vice President of Human Resources. She joined the Company with over 20 years of leadership experience in human resources and strategic talent management in the healthcare and technology industries. Prior to joining Viveve, she served six years as Vice President of Talent Management and Chief Administrative Officer at The Breakaway Group, a Colorado-based business that develops simulation education of HIT applications for over 1 million healthcare provider end users. Ms. McMillan has held senior leadership positions demonstrating success in creating and implementing effective human capital and operational strategies in support of organizations’ mission, values, and goals. She served as a human resources executive at the Association of periOperative Registered Nurses (AORN) from 2004 to 2011 and Evolving Systems, Inc., a software company which tripled in size prior to their IPO in 1998. Early in her career, she held management and sales executive positions in the cosmetics and fragrance industries with Estee Lauder and Riviera Concepts.
Ms. McMillan received her B. A. in Sociology at Colorado State University and completed HR executive and business education programs at Stanford University and Vassar College.
Michael Krychman, M.D.
Consulting Medical Director
Dr. Krychman is Executive Director, President, and CEO of the Southern California Center for Sexual Health and Survivorship Medicine and Associate Clinical Professor at the University of California, Irvine, Department of Obstetrics and Gynecology. He is a Member of the International Society for the Study of Women's Sexual Health (ISSWSH), The International Society for Sexual Medicine (ISSM) and a Certified Sexual Counselor by the American Association of Sexuality Educators, Counselors and Therapists (AASECT). He served as a member of the Standards Committee for the International Society for Sexual Medicine during their 2016 International Consensus Meeting.
Dr. Krychman is an internationally recognized expert and author of numerous books addressing sexual health conditions, therapies, and treatments. He also is a primary and contributing author of many scientific clinical papers, manuscripts and presentations. Frequently asked to share his knowledge on sexual health issues, Dr. Krychman has been quoted in The Wall Street Journal, The New York Times and other media and press.
He has been a visiting professor at Oxford University in the United Kingdom and has served in a consulting or advisory board role for many women's health companies including SHIONOGI, Boehringer Ingelheim, Pfizer Women's Healthcare, and Viveve Medical, Inc.